Status:
UNKNOWN
Translation and Validation of the German Version of the Toronto Extremity Salvage Score (TESS) and Musculoskeletal Tumor Society (MSTS)
Lead Sponsor:
Medical University Innsbruck
Conditions:
Sarcoma
Eligibility:
All Genders
18-99 years
Brief Summary
The MSTS is an evaluation tool used worldwide to assess physical function in patients with musculoskeletal tumors. The questionnaire has already been successfully translated and validated in Portugues...
Detailed Description
The most common primary bone tumors include osteosarcoma, Ewing's sarcoma and chondrosarcoma. The main symptom in patients with primary bone tumors is pain that can occur at rest or at night. The phys...
Eligibility Criteria
Inclusion
- The questionnaire will be tested on patients who are undergoing extremity-conserving surgery for sarcomas at one of the participating centers as part of the clinical routine. The patients are addressed preoperatively by a member of the study team and during their stay in the clinic whether they participate in the study.
Exclusion
- Patients who cannot be treated for extremities and patients who are unable to consent are excluded from the study.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04327908
Start Date
June 1 2020
End Date
June 1 2023
Last Update
April 1 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.